Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profile Solutions Inc PSIQ

Healthcare Drug Manufacturers - Specialty & Generic
Profile Solutions, Inc., through its subsidiary Elite Products International, Inc. is a distributor and manufacturer in the cannabinoid (CBD) industry. The Company’s products contain CBD Hemp extracts in the form of edibles, creams, oils, and salves. Its product categories include gummies, such as Delta 8 Gummies, Delta 9 Gummies, Delta 10 Gummies, HHC Gummies, Sleep Gummies, Energy Gummies... see more

Recent & Breaking News (GREY:PSIQ)

PSIQ Terminates Letter of Intent to Acquire Ecoland

GlobeNewswire September 19, 2019

PSIQ Completes 2018 Year-End Audit

GlobeNewswire July 17, 2019

PSIQ and Ecoland Agree to Extension

GlobeNewswire July 1, 2019

PSIQ Responds to SEC Trading Suspension

GlobeNewswire June 21, 2019

PSIQ Closes Deal to Acquire License to Prepare Land to Grow, Cultivate, Distribute and Export Israel Medical Cannabis

GlobeNewswire June 11, 2019

PSIQ to Exhibit at ASD Market Week, the Most Comprehensive B2B Trade Show for Consumer Merchandise in the United States July 28th Through July 31st, 2019

GlobeNewswire June 6, 2019

PSIQ Aiming to Significantly Bolster Revenues and Market Share by Attending Champs Trade Show, the Premier Counterculture B2B Expo at Atlantic City, New Jersey Convention Center May 21st, 2019 Through May 23rd, 2019

GlobeNewswire May 23, 2019

PSIQ to Acquire 80% of Ecoland Including Multiple Cannabis Licenses, Operations and Real Estate for Approximately $18,300,000

GlobeNewswire May 8, 2019

NOTICE TO DISREGARD - Profile Solutions, Inc.

GlobeNewswire April 30, 2019

PSIQ ANNOUNCES RESELLER AGREEMENT WITH CANNARA BIOTECH SUBSIDIARY SHOPCBD.COM TO MARKET AND SELL ELITES CBD PRODUCT LINE WITHIN THE UNITED STATES

GlobeNewswire April 30, 2019

PSIQ Announces CBD Flower Added to Product Line, Creating Substantial Revenue Opportunity

GlobeNewswire April 18, 2019

BEMG Announces Dan Oran as New Officer & Director to Enhance Shareholder Value

GlobeNewswire April 9, 2019

PSIQ Reports Record Breaking Annual Revenues of $ 876,448 for 2018 as Compared to $ 208,236 for 2017, an Increase of Over 400% and Poised for Rapid Expansion in 2019

GlobeNewswire April 4, 2019

UPDATE -- PSIQ to Receive Assignment of License to Prepare Land in Israel With the Intent to Grow, Cultivate, Distribute and Export Medical Cannabis to the Projected $57 Billion Global Legal Cannabis Market

GlobeNewswire April 3, 2019

PSIQ to Receive Assignment of License to Prepare Land in Israel With the Intent to Grow, Cultivate, Distribute and Export Medical Cannabis to the Projected $57 Billion Global Legal Cannabis Market

GlobeNewswire March 27, 2019

PSIQ Grants Distribution Rights to Paraguay, Chile, and Brazil With First Year Minimum Guarantee of $500,000 and 20% Growth Per Year Thereafter

GlobeNewswire March 21, 2019

PSIQ Files Amendment # 1 to Form S-1 as the Next Step to Becoming an SEC Reporting Issuer and Uplisting to OTCQB

GlobeNewswire March 6, 2019

PSIQ to Attend and Display at Champs Trade Show, the Premier Counterculture B2B Expo Since 1999 at the Las Vegas Convention Center February 27th, 2019 Through March 1st, 2019

GlobeNewswire February 26, 2019

PSIQ Executes Agreement to Distribute Its Cutting-Edge CBD Hemp Extracts to the Projected $ 12 Billion Mall Cart & Kiosk Industry in the United States

GlobeNewswire February 20, 2019

PSIQ Enters the Projected $ 60 Billion Global Kosher Food Market

GlobeNewswire February 14, 2019